Saturday 17 October 2026
Export POCI’s income statement to Excel — free account
Precision Optics Corp.
POCI Healthcare Medical Instruments & Supplies
Precision Optics Corp.’s revenue for fiscal 2026 (year ended June 2026) was $31.5 million, up 65.2% from fiscal 2025. In the quarter to June 2026, revenue grew 42.0%, EPS grew 117.4%, free cash flow fell 45.6% and total debt fell 31.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.26
0.09
−2.07%
Follow POCI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.38 | 1.18 | 1.32 | 1.56 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(67.03) | (47.31) | (126.22) | 429.16 | |
P/B ratio |
2.14 | 1.70 | 3.46 | 3.07 | |
Price to Tangible BV |
3.85 | 3.09 | 113.23 | 17.92 | |
EV/Sales |
1.11 | 0.86 | 1.35 | 1.57 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(22.55) | (18.94) | (13.38) | (11.30) | |
EV/FCF |
(17.66) | (14.26) | (10.86) | (9.67) | |
Quick Ratio |
1.79 | 1.69 | 0.58 | 0.73 | |
Current Ratio |
2.28 | 2.10 | 1.05 | 1.29 | |
Net Debt/EBITDA |
202.65 | (833.01) | (0.42) | (0.22) | |
Debt/Assets |
3.99% | 4.26% | 6.89% | 7.70% | |
Debt/Equity |
0.06 | 0.07 | 0.17 | 0.16 | |
Asset Turnover |
1.21 | 1.09 | 1.21 | 1.09 | |
Operating CF/Net income |
6.25 | 6.68 | 0.14 | (0.05) | |
Capex/Depreciation |
(1.25) | 0.65 | (1.30) | (4.63) | |
Interest Coverage |
(3.25) | (1.84) | (45.25) | (38.17) | |
Research and Development Expense of Revenue |
2.33% | 3.07% | 3.39% | 4.67% | |
Selling, General and Administrative Expense of Revenue |
24.23% | 21.29% | 23.04% | 33.38% | |
Intangible Assets out of Total Assets |
0.28 | 0.27 | 0.40 | 0.40 | |
Share Based Compensation of Revenue |
4.53% | 2.91% | 2.54% | 4.51% | |
Graham Net Nets |
0.19 | 0.23 | (0.10) | (0.05) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(8.28%) | (14.44%) | (21.96%) | (19.31%) | |
Free Cash Flow Yield |
(4.55%) | (5.12%) | (9.40%) | (10.45%) | |
Revenue per Share |
1.03 | 1.12 | 0.96 | 0.87 | |
Operating CF per Share |
(0.08) | (0.09) | (0.03) | 0.01 | |
Capex per Share |
(0.01) | 0.01 | (0.01) | (0.04) | |
Free Cash Flow per Share |
(0.09) | (0.09) | (0.05) | (0.03) | |
Cash per Share |
1.15 | 1.37 | 0.11 | 0.18 | |
Shareholders Equity per Share |
2.39 | 2.58 | 1.21 | 1.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.39 | 2.58 | 1.21 | 1.42 | |
Free Cash Flow |
(0.73) | (0.67) | (0.35) | (0.22) | |
Working Capital |
11.28 | 11.21 | 0.47 | 2.24 | |
Capital Expenditures |
(0.08) | 0.05 | (0.10) | (0.30) | |
Net Current Asset Value |
8.12 | 7.83 | (3.14) | (1.60) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | (0.01) | 0.01 | 0.05 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
5.14 | 5.00 | 4.19 | 3.66 | |
Average Payables |
3.25 | 4.06 | 4.39 | 3.08 | |
Average Inventory |
3.70 | 3.69 | 4.06 | 3.67 | |
Average Assets |
26.06 | 26.65 | 20.20 | 19.81 | |
Average Common Equity |
16.30 | 16.64 | 9.40 | 10.53 |
Columns are period end dates · fundamentals updated 30 Sep 2026